Evidence map›Paper›PMID 32060489›Full record

ArticleNature genetics2020

A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo.

Masayuki Nakamori, Gagan B Panigrahi, Stella Lanni, Terence Gall-Duncan, Hideki Hayakawa, Hana Tanaka, Jennifer Luo, Takahiro Otabe, Jinxing Li, Akihiro Sakata and 22 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 146 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 4 countries.

Masayuki Nakamori *Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Gagan B Panigrahi *Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-5750-6051
Stella Lanni *Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Terence Gall-DuncanProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Hideki HayakawaDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hana TanakaDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Jennifer LuoProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Takahiro OtabeDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.
Jinxing LiDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.
Akihiro SakataDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.
Marie-Christine CaronGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Niraj JoshiGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Tanya PrasolavaProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Karen ChiangProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Jean-Yves MassonGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Marc S WoldDepartment of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Xiaoxiao WangDepartment of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.ORCID http://orcid.org/0000-0002-9913-680X
Marietta Y W T LeeDepartment of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.ORCID http://orcid.org/0000-0001-8696-6962
John HuddlestonDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Katherine M MunsonDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8413-6498
Scott DavidsonProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Mehdi LayeghifardProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Lisa-Monique EdwardProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Richard GallonInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Mauro Santibanez-KorefInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Asako MurataDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.
Masanori P TakahashiDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0002-5513-5012
Evan E EichlerDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8246-4014
Adam ShlienProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Kazuhiko NakataniDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0002-1705-5265
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0002-0874-7542
Christopher E PearsonProgram of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada. cepearson.sickkids@gmail.com.ORCID http://orcid.org/0000-0001-9545-4205
The University of Osaka · JPHospital for Sick Children · CAUniversity of Toronto · CAUniversité Laval · CAHoward Hughes Medical Institute · USNewcastle University · GBNew York Medical College · USUniversity of Iowa · USUniversity of Washington · US

Funding

Sequence-resolved structural variation of human genomesR01HG010169 · NHGRI · UNIVERSITY OF WASHINGTON · PI Evan Eichler · 2018 to 2026
$4.5M
Modification of DNA Polymerase Delta by a Novel Mechanism During Replication StreR01ES014737 · NIEHS · NEW YORK MEDICAL COLLEGE · PI LEE, MARIETTA Y., ZHANG, ZHONGTAO · 2008 to 2017
$3.5M
Cancer Research UK 24991NHGRI NIH HHS R01 HG010169NIEHS NIH HHS R01 ES014737
6 · The paper itself

Abstract

In many repeat diseases, such as Huntington's disease (HD), ongoing repeat expansions in affected tissues contribute to disease onset, progression and severity. Inducing contractions of expanded repeats by exogenous agents is not yet possible. Traditional approaches would target proteins driving repeat mutations. Here we report a compound, naphthyridine-azaquinolone (NA), that specifically binds slipped-CAG DNA intermediates of expansion mutations, a previously unsuspected target. NA efficiently induces repeat contractions in HD patient cells as well as en masse contractions in medium spiny neurons of HD mouse striatum. Contractions are specific for the expanded allele, independently of DNA replication, require transcription across the coding CTG strand and arise by blocking repair of CAG slip-outs. NA-induced contractions depend on active expansions driven by MutSβ. NA injections in HD mouse striatum reduce mutant HTT protein aggregates, a biomarker of HD pathogenesis and severity. Repeat-structure-specific DNA ligands are a novel avenue to contract expanded repeats.

Indexed as

AnimalsCorpus StriatumDisease Models, AnimalDNADNA Mismatch RepairDNA ReplicationHumansHuntingtin ProteinHuntington DiseaseMaleMiceMice, TransgenicMicrosatellite InstabilityMutationNaphthyridinesQuinolonesDNAHTT protein, humanHtt protein, mouseHuntingtin Proteinnaphthyridine-azaquinoloneNaphthyridinesQuinolonesRibonucleasesTATA-Box Binding ProteinTBP protein, human

Identifiers

PMID32060489
PMCPMC7043212
OpenAlexW3005905327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.